ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 71

Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia  Polysymptomatic Distress Scale

Laura-Aline Martinez-Martinez1, Maya Chacón Pérez2, Paola Reyes-Loyola3 and Manuel Martínez-Lavín3, 1National Institute of Cardiology. Mexico, Mexico City, TX, Mexico, 2National Institute of Cardiology, Mexico City, Mexico, 3National Institute of Cardiology. Mexico, Mexico City, Mexico

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Autonomic disorders, Diagnostic criteria, fibromyalgia and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

A consistent line of investigation suggests that dysautonomia may explain the multisystem fibromyalgia features, and that fibromyalgia is a sympathetically maintained neuropathic pain syndrome. The sympathetic nervous network is the main component of the stress response system (Arthritis Res Ther. 2007;9:216).  

The ACR 2010 preliminary fibromyalgia diagnostic criteria is based on the Polysymptomatic Distress Scale. According to its developers, this scale is able to assess illness severity while still allowing a dichotomous diagnosis (Arthritis Care Res. 2010;62:600). We noted that Polysymptomatic Distress Scale items have clear dysautonomia connotations.

COMPASS-31 is a newly developed questionnaire to appraise dysautonomia. In contrast to the old COMPASS questionnaire, this new version has simplified scoring algorithm, and is suitable for widespread use in autonomic research and practice (Mayo Clin Proc. 2012;87:1196).

 The objectives of our study were:  1) To correlate COMPASS-31 with the Polysymptomatic Distress Scale and with the Fibromyalgia Impact Questionnaire in 3 different groups of adult women:  patients with fibromyalgia, patients with rheumatoid arthritis or healthy controls. 2) To compare the burden of dysautonomia symptoms in these 3 groups of individuals.  

Methods: ,

To date, we have studied 25 women with fibromyalgia (ACR 1990 + ACR 2010 criteria), 19 with active rheumatoid arthritis (ACR criteria) and 24 healthy controls. All participants filled out the following questionnaires:  COMPASS-31, Fibromyalgia Impact Questionnaire, and Polysymptomatic Distress Scale.

Results:

Age was similar in the 3 studied groups (mean: 41 years). In fibromyalgia patients there was correlation between COMPASS-31 scores and Polysymptomatic Distress Scale (Spearman Rho = 0.583, p = 0.002) and between COMPASS-31 and Fibromyalgia Impact Questionnaire (Rho = 0.525, p = 0.007).  Remarkably, there was a strong correlation between COMPASS-31 scores and pain VAS values (Rho = 0.721, p <0.0001). Patients with rheumatoid arthritis did not display such COMPASS 31 –  pain VAS values correlation (Rho = – 0.024, p = 0.92). Patients suffering from fibromyalgia had much higher COMPASS-31 values (39.7 ± 15.3) when compared with rheumatoid arthritis patients (9.5 ± 8.5) and healthy controls (9.05 ± 8.7) p <0.0001.

Conclusion:

Patients suffering from fibromyalgia have much more dysautonomia symptoms when compared to rheumatoid arthritis patients. In fibromyalgia, but not in rheumatoid arthritis, pain is closely related to autonomic dysfunction. There is correlation between the Polysymptomatic Distress Scale and COMPASS-31. Therefore, dysautonomia rather than “polysymptomatic distress” may be fibromyalgia’s underlying pathogenesis. COMPASS-31 may become a useful clinical instrument to evaluate fibromyalgia’s multisystem features.


Disclosure: L. A. Martinez-Martinez, None; M. Chacón Pérez, None; P. Reyes-Loyola, None; M. Martínez-Lavín, None.

To cite this abstract in AMA style:

Martinez-Martinez LA, Chacón Pérez M, Reyes-Loyola P, Martínez-Lavín M. Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia  Polysymptomatic Distress Scale [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fibromyalgia-dysautonomia-and-distress-correlation-between-the-newly-developed-composite-autonomic-symptoms-compass-31-questionnaire-and-the-fibromyalgia-polysymptomatic-distress-scale/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibromyalgia-dysautonomia-and-distress-correlation-between-the-newly-developed-composite-autonomic-symptoms-compass-31-questionnaire-and-the-fibromyalgia-polysymptomatic-distress-scale/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology